FDA Approves First Ever 'Biosimilar' Drug for Use in the U.S.

March 8, 2015 9:44 AM

13 0

(Photo : REUTERS/ARND WIEGMANN) The logo of Swiss drugmaker Novartis is seen at its headquarters in Basel.

The U.S. Food and Drug Administration (FDA) on Feb. 6 approved "filgrastim-sndz," the first "biosimilar" or non-brand, complex biopharmaceutical in U.S. pharmaceutical history.

Read more

To category page